ATRC vs CUBE · rev $465.3M vs P/E 25, rev $1.07B
AtriCure Inc (ATRC) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ATRC revenue for 2024-12-31 was $465.3M. Net income was -$44.7M. Revenue was up 16.5% from 2023-12-31 to 2024-12-31. ATRC currently screens at market cap $1.37B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ATRC currently screens at market cap $1.37B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ATRC and CUBE stock pages for the full models.
Not investment advice.